{"adverse_reactions":["Sincerus Florida, LLC. Adverse reaction vb"],"components":["Active, inactive sdf"],"effective_time":"20190520","id":"89585e3f-167f-dd3b-e053-2995a90ade55","instructions_for_use":["Directions for use as"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 6067-2 DESOXIMETASONE USP 0.05% / HYDROQUINONE USP 6% / TRETINOIN USP 0.05%. Emulsion 30 gm qq"],"set_id":"89585e3f-167e-dd3b-e053-2995a90ade55","spl_product_data_elements":["DESOXIMETASONE 0.05% / HYDROQUINONE 6% / TRETINOIN 0.05% DESOXIMETASONE 0.05% / HYDROQUINONE 6% / TRETINOIN 0.05% DESOXIMETASONE DESOXIMETASONE HYDROQUINONE HYDROQUINONE TRETINOIN TRETINOIN"],"version":"1"}